Company:  ENDOLOGIX INC /DE/ (ELGX)
Form Type:  10-Q
Filing Date:  8/9/2019 
CIK:  0001013606 
Address:  2 MUSICK 
City, State, Zip:  IRVINE, California 92618 
Telephone:  (949) 598-4741 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.23  
Change: 
-0.13 (-2.98%)  
Trade Time: 
03:26 PM EST  
Market Cap: 
$74.50M
Trade ELGX now with

© 2019  
Description of Business
We develop, manufacture, market and sell innovative medical devices for the treatment of aortic disorders. Our products are intended for the minimally invasive endovascular treatment of abdominal aortic aneurysms ("AAA"). Our AAA products are built on one of two platforms: * Traditional minimally-invasive endovascular aneurysm repair ("EVAR"); or * Endovascular aneurysm sealing ("EVAS"), our innovative solution for sealing the aneurysm sac while maintaining blood flow. Our current EVAR products include the AFX® Endovascular AAA System (the "AFX System"), the VELA® Proximal Endograft ("VELA") and the Ovation® Abdominal Stent Graft System (the "Ovation System"). Our current EVAS product is the Nellix® Endovascular Aneurysm Sealing System (the "Nellix EVAS System").
Register and access this filing in:     
  FORM 10-Q
    Part I. Financial Information
      FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
          BALANCE SHEET
      Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF ...
      Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      Item 4. CONTROLS AND PROCEDURES.
    Part II. Other Information
      Item 1. LEGAL PROCEEDINGS
      Item 1A.RISK FACTORS
        BENEFICIAL OWNERS
      Item 6. EXHIBIT INDEX
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 10.3
  EXHIBIT 10.4
  EXHIBIT 31.1
  EXHIBIT 31.2
  EXHIBIT 32.1
  EXHIBIT 32.2